VCN Biosciences
Pioneering advanced tumor treatments through innovative oncolytic virus technology.
Pioneering advanced tumor treatments through innovative oncolytic virus technology.
VCN Biosciences is a biotechnology startup founded in 2009 with a focus on pioneering advanced tumor treatments. The company specializes in the research and development of new treatments for tumors, utilizing oncolytic virus technology. In July 2012, VCN Biosciences secured its last investment in a funding round led by Grifols, demonstrating strong support from established players in the industry. With a commitment to innovation in the biotechnology sector, VCN Biosciences is positioned to make a significant impact in the development of cutting-edge tumor treatments.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Funding Round | Unknown | 1 | Grifols | 09 Jul 2012 |
No recent news or press coverage available for VCN Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
